Cationic liposomes coated with polyethylene glycol as carriers for oligonucleotides

被引:192
作者
Meyer, O
Kirpotin, D
Hong, KL
Sternberg, B
Park, JW
Woodle, MC
Papahadjopoulos, D
机构
[1] Calif Pacific Med Ctr, Res Inst, Liposome Res Lab, San Francisco, CA 94115 USA
[2] Genet Therapy Inc, Gaithersburg, MD 20878 USA
[3] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Med, Div Hematol Oncol, San Francisco, CA 94143 USA
关键词
D O I
10.1074/jbc.273.25.15621
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Modification of liposome surface with polyethylene glycol was used to improve oligodeoxyribonucleotide (ODN) loading, stability of the resulting complexes, and specificity of cellular delivery of ODN by cationic liposomes. Liposomes composed of a cationic lipid (DOTAP, DOGS, DDAB), a neutral lipid (DOPE), and a phospholipid derivative of polyethylene glycol (PEG-PE) formed a complex with 18-mer phosphorothioate up to ODN/lipid molar ratio of 0.25, The complexes showed intact vesicular structures similar to original liposomes and their size (100-130 nm) was unchanged after several weeks of storage, whereas complexes lacking PEG-PE showed progressive aggregation and/or precipitation. After exposure to human plasma, PEG-modified cationic liposomes retained over 60% of the originally bound ODN, PEG-coated complexes resulted in 4-13-fold enhancement of the ODN uptake by human breast cancer cells in serum-supplemented growth medium, relative to free ODN, Complexes containing conjugated anti-HER2 F(ab') fragments at the distal termini of PEG chains efficiently delivered ODN primarily irate che cytoplasm and nuclei of HERS overexpressing cancer cells and greatly enhanced the biological activity of antisense ODN. The development of PEG-modified cationic liposomes may lead to improved ODN potency in vivo.
引用
收藏
页码:15621 / 15627
页数:7
相关论文
共 29 条
[1]   A NEW STRATEGY FOR ATTACHMENT OF ANTIBODIES TO STERICALLY STABILIZED LIPOSOMES RESULTING IN EFFICIENT TARGETING TO CANCER-CELLS [J].
ALLEN, TM ;
BRANDEIS, E ;
HANSEN, CB ;
KAO, GY ;
ZALIPSKY, S .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1995, 1237 (02) :99-108
[2]  
BAGG A, 1993, ONCOGENES TUMOR SUPP, P141
[3]  
BENNETT CF, 1992, MOL PHARMACOL, V41, P1023
[4]   LIPOFECTION - A HIGHLY EFFICIENT, LIPID-MEDIATED DNA-TRANSFECTION PROCEDURE [J].
FELGNER, PL ;
GADEK, TR ;
HOLM, M ;
ROMAN, R ;
CHAN, HW ;
WENZ, M ;
NORTHROP, JP ;
RINGOLD, GM ;
DANIELSEN, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (21) :7413-7417
[5]   INTRACELLULAR DISPOSITION AND METABOLISM OF FLUORESCENTLY-LABELED UNMODIFIED AND MODIFIED OLIGONUCLEOTIDES MICROINJECTED INTO MAMMALIAN-CELLS [J].
FISHER, TL ;
TERHORST, T ;
CAO, XD ;
WAGNER, RW .
NUCLEIC ACIDS RESEARCH, 1993, 21 (16) :3857-3865
[6]  
HALDAR S, 1994, CANCER RES, V54, P2095
[7]   Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery [J].
Hong, KL ;
Zheng, WW ;
Baker, A ;
Papahadjopoulos, D .
FEBS LETTERS, 1997, 400 (02) :233-237
[8]   2 TECHNIQUES FOR EVALUATING SMALL MOLECULE-MACROMOLECULE BINDING IN COMPLEX SYSTEM [J].
HUNSTON, DL .
ANALYTICAL BIOCHEMISTRY, 1975, 63 (01) :99-109
[9]   OLIGONUCLEOTIDE-CATIONIC LIPOSOME INTERACTIONS - A PHYSICOCHEMICAL STUDY [J].
JAASKELAINEN, I ;
MONKKONEN, J ;
URTTI, A .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1994, 1195 (01) :115-123
[10]   STRUCTURE AND PHASE-BEHAVIOR OF LIPID SUSPENSIONS CONTAINING PHOSPHOLIPIDS WITH COVALENTLY ATTACHED POLY(ETHYLENE GLYCOL) [J].
KENWORTHY, AK ;
SIMON, SA ;
MCINTOSH, TJ .
BIOPHYSICAL JOURNAL, 1995, 68 (05) :1903-1920